Individuals 18 years of age and older with Chronic Spontaneous Urticaria (CSU) lasting 6 months or more, may qualify to participate. Eligible participants must have the presence of itch and hives for 6 consecutive weeks or more prior to screening, despite the use of second generation H1-antihistamines. Documentation of hives within 3 months before randomization into the study, is also required.
Participants will receive an oral investigational medication (active study drug) or placebo. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last about 60 weeks and involve about 13 visits to the study centre.
Call the study centre near you, or register now.
All information about you will be kept confidential.
If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.
By registering you are consenting to the terms and conditions of our privacy policy.
Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more
© 2014 All Rights Reserved Probity Medical Research Inc.